Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Therapeutic implications of autophagy-mediated cell survival in gastrointestinal stromal tumor after treatment with imatinib mesylate.

Rubin BP, Debnath J.

Autophagy. 2010 Nov;6(8):1190-1. doi: 10.4161/auto.6.8.13430. Epub 2010 Nov 16. No abstract available.

2.

Critical update and emerging trends in imatinib treatment for gastrointestinal stromal tumor.

De Giorgi U, Pupi A, Turrisi G, Montenora I, Morini S, Fayyaz M, De Simone M, Fiorentini G.

Rev Recent Clin Trials. 2007 Jan;2(1):43-8. Review.

PMID:
18473987
3.

Some lessons learned from imatinib mesylate clinical development in gastrointestinal stromal tumors.

Casali PG, Bertulli R, Fumagalli E, Coco P, Grosso F, Stacchiotti S.

J Chemother. 2004 Nov;16 Suppl 4:55-8. Review.

PMID:
15688611
4.

[A case of a giant rectal gastrointestinal stromal tumor radically resectable after treatment with neoadjuvant imatinib mesylate].

Sassa M, Kobayashi Y, Sugeno H, Iwadate M, Suzuki S, Endo Y, Nakamura I, Ohki S, Takenoshita S.

Gan To Kagaku Ryoho. 2013 Jul;40(7):937-41. Review. Japanese.

PMID:
23863741
5.

[KIT mutation analysis in pathological diagnosis and target-therapy of gastrointestinal stromal tumors: an update].

Chen LR.

Zhonghua Bing Li Xue Za Zhi. 2007 Jul;36(7):440-3. Review. Chinese. No abstract available.

PMID:
17845754
6.

Gastrointestinal stromal tumours: etiology, pathology and clinical management.

Blackstein ME, Dubé P, Fletcher JA, Keller OR, Knowling M, Létourneau R, Morris D, Riddell R, Rorke S, Swallow CJ; Canadian Advisory Committee on GIST.

Can J Gastroenterol. 2004 Sep;18 Suppl B:3B-8B. Review.

PMID:
15457300
7.

[Gastrointestinal stromal tumor of small intestine associated with lymph node metastasis: a report of 2 cases with review of literatures].

Kong M, Wang YL, Xu LJ, Teng XD.

Zhonghua Bing Li Xue Za Zhi. 2009 Sep;38(9):617-20. Review. Chinese.

PMID:
20079191
8.

The role of imatinib plasma level testing in gastrointestinal stromal tumor.

George S, Trent JC.

Cancer Chemother Pharmacol. 2011 Jan;67 Suppl 1:S45-50. doi: 10.1007/s00280-010-1527-2. Epub 2010 Dec 8. Review.

PMID:
21140148
9.

[Autophagy in hematologic malignancies].

Adachi S.

Rinsho Ketsueki. 2009 Oct;50(10):1531-8. Review. Japanese. No abstract available.

PMID:
19915363
10.

Imatinib mesylate for the treatment of gastrointestinal stromal tumor.

Cassier PA, Blay JY.

Expert Rev Anticancer Ther. 2010 May;10(5):623-34. doi: 10.1586/era.10.33. Review.

PMID:
20469993
11.
12.

Gastrointestinal stromal tumours (GISTs): case report and review of the literature.

Al-Amri AM, Shawarbi MA, El-Hassan AY, Al-Johi KS.

Gulf J Oncolog. 2011 Jan;(9):57-60. Review.

PMID:
21177210
13.

The DREAM complex in antitumor activity of imatinib mesylate in gastrointestinal stromal tumors.

DeCaprio JA, Duensing A.

Curr Opin Oncol. 2014 Jul;26(4):415-21. doi: 10.1097/CCO.0000000000000090. Review.

14.

Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis.

Ravegnini G, Sammarini G, Nannini M, Pantaleo MA, Biasco G, Hrelia P, Angelini S.

Autophagy. 2017 Mar 4;13(3):452-463. doi: 10.1080/15548627.2016.1256522. Epub 2017 Jan 5. Review.

Supplemental Content

Support Center